Case managers and medical directors need to be familiar with all the aspects of clinical management including diagnosis, prognostic stratification, treatment options, assessment of response to treatment, supportive care and survivorship care.

Case managers and medical directors need to be familiar with all the aspects of clinical management including diagnosis, prognostic stratification, treatment options, assessment of response to treatment, supportive care and survivorship care.

Many patients with hematologic malignancies are at risk for treatment-induced bone loss which in turn can result in pathologic fractures, hypercalcemia, bone pain, and decline in motility and performance status.

Hematopoietic cell transplant (HCT) in an outpatient setting requires well-defined coordinated care by a dedicated team including transplant physician, oncology nurse with expertise in caring for patients receiving HCT, and a competent full-time caregiver.

Chronic graft-versus-host disease (GVHD) is a potentially serious complication that significantly impacts quality of life in patients undergoing allogeneic hematopoietic cell transplant.  Treatment of chronic GVHD can be optimized by providing coordinated care involving a multidisciplinary team p

This information was originally presented at the NCCN 11^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances.

The NCCN Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ at the NCCN 12^th Annual Congress: Hematologic Malignancies™ will provide hematology/oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.